Trilostane therapy for hyperadrenocorticism in three dogs with adrenocortical metastasis

Veterinary Record

Volumn 163, Issue 6, 2008, Pages 190-192

  Benchekroun, G ^a   De Fornel Thibaud, P ^b   Lafarge, S ^c   Gomez, E ^a   Begon, D ^a   Delisle, F ^b   Moraillon, R ^a   Heripret D ^c   Maurey, C ^a   Rosenberg, D ^a  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b Veterinary Cancer Centre   (France)

^c Frégis Animal Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 50249134799     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.163.6.190     Document Type: Article

References (15)

1. BARKER, E. N., CAMPBELL, S., TEBB, A. J., NEIGER, R., HERRTAGE, M. E., REID, S. W. & RAMSEY, I. K. (2005) A comparison of the survival times of dogs treated with mitotane or trilostane for pituitary-dependent hyperadrenocorticism. Journal of Veterinary Internal Medicine 19, 810-815
2. EASTWOOD, J. M., ELWOOD, C. M. & HURLEY, K. J. (2001) Trilostane treatment of four dogs with functional adrenocortical neoplasia. Proceedings of the 11th European Society of Veterinary Medicine. Dublin, Ireland, September 5 to 8, 2001. p 185
3. EASTWOOD, J. M., ELWOOD, C. M. & HURLEY, K. J. (2003) Trilostane treatment of a dog with functional adrenocortical neoplasia. Journal of Small Animal Practice 44, 126-131
4. FELDMAN, E. C. & NELSON, R. W. (2004a) Beta-cell neoplasia: insulinoma. In Canine and Feline Endocrinology and Reproduction. 3rd edn. Eds E. C. Feldman, R. W. Nelson. St Louis, Saunders. pp 616-644
5. FELDMAN, E. C. & NELSON, R. W. (2004b) Hyperadrenocorticism (Cushing's syndrome). In Canine and Feline Endocrinology and Reproduction. 3rd edn. Eds E. C. Feldman, R. W. Nelson. St Louis, Saunders. pp 252-357
6. FELDMAN, E. C., NELSON, R. W. & FELDMAN, M. S. (1996) Use of low-and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs. Journal of the American Veterinary Medical Association 209, 772-775
7. GRANGER, N., DE FORNEL, P., DEVAUCHELLE, P., SEGOND, S., DELISLE, F. & ROSENBERG, D. (2005) Plasma pro-opiomelanocortin, pro-adrenocorticotropin hormone, and pituitary adenoma size in dogs with Cushing's disease. Journal of Veterinary Internal Medicine 19, 23-28
8. HANSEN, B. L., KEMPPAINEN, R. J. & MACDONALD, J. M. (1994) Synthetic ACTH (Cosyntropin) stimulation tests in normal dogs: comparison of intravenous and intramuscular administration. Journal of the American Animal Hosptial Association 30, 38-41
9. HURLEY, K., STRUGESS, K., CAUVIN, A. & KUIPERS, R. (1998) The use of trilostane for the treatment of hyperadrenocorticsm in dogs. Journal of Veterinary Internal Medicine 12, 210
10. KEISER, M., FLÜCKIGER, M., GARDELLE, O. & REUSCH, C. E. (1999) Mitotane treatment in a dog with a recurring adrenocortical carcinoma - a case report. Schweizer Archive für Tierheilkund 141, 279-285 (In German)
11. KINTZER, P. P. & PETERSON, M. E. (1994) Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms. Journal of the American Veterinary Medical Association 205, 54-61
12. NEIGER, R. & HURLEY, K. (2000) Long term efficacy and safety of trilostane for treatment of canine hyperdrenocorticism. Journal of Veterinary Internal Medicine 14, 376
13. NEIGER, R., RAMSEY, I., O'CONNOR, J., HURLEY, K. J. & MOONEY, C. T. (2002) Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Veterinary Record 150, 799-804
14. REUSCH, C. E. & FELDMAN, E. C. (1991) Canine hyperadrenocorticism due to adrenocortical neoplasia. Pretreatment evaluation of 41 dogs. Journal of Veterinary Internal Medicine 5, 3-10
15. RUCKSTUHL, N. S., NETT, C. S. & REUSCH, C. E. (2002) Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. American Journal of Veterinary Research 63, 506-512